Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart FailureGlobeNewsWire • 12/14/20
MESO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 7, 2020 in the Class Action Filed on Behalf of Mesoblast Limited Limited ShareholdersNewsfile Corp • 12/07/20
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mesoblast Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2020 - MESONewsfile Corp • 12/07/20
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/07/20
MESO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020GlobeNewsWire • 12/07/20
MESO Final Deadline Today: Rosen, Leading Trial Attorneys, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESONewsfile Corp • 12/07/20
Remestemcel-L Reduces Inflammatory Biomarkers Predictive of High Mortality in Acute Graft Versus Host DiseaseGlobeNewsWire • 12/07/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline - MESOPRNewsWire • 12/05/20
MESO FINAL DEADLINE MONDAY: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action – MESOBusiness Wire • 12/05/20
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mesoblast Limited and Encourages Investors to Contact the FirmBusiness Wire • 12/05/20
MESO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020Business Wire • 12/04/20
DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/04/20
Mesoblast Limited Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law FirmGlobeNewsWire • 12/04/20
MESO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action – MESOGlobeNewsWire • 12/03/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/03/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/02/20
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19GlobeNewsWire • 12/02/20
Rosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 12/01/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/01/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESOPRNewsWire • 11/28/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline – MESOGlobeNewsWire • 11/26/20
ROSEN, A TOP RANKED FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESONewsfile Corp • 11/21/20